Prevalence of osteonecrosis of the jaw and oral characteristics of oncologic patients treated with bisphosphonates at the General Hospital of Mexico

To determine the prevalence and oral characteristics of cancer patients treated with bisphosphonates in the oncology and maxillofacial prosthesis departments of the General Hospital of Mexico between 2011 and 2013. This cross-sectional study included patients who received prior treatment with bispho...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the Korean Association of Oral and Maxillofacial Surgeons 2016, 42(6), , pp.365-369
Main Authors: Cuevas-González, María Verónica, Díaz-Aguirre, Celia Minerva, Echevarría-Y-Pérez, Enrique, Cuevas-González, Juan Carlos
Format: Article
Language:English
Subjects:
Original
치의학
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To determine the prevalence and oral characteristics of cancer patients treated with bisphosphonates in the oncology and maxillofacial prosthesis departments of the General Hospital of Mexico between 2011 and 2013. This cross-sectional study included patients who received prior treatment with bisphosphonates; an intraoral examination was performed by 2 standardized examiners. The prevalence of bisphosphonate-related necrosis in 75 patients was 2.6%; the most common malignancy was breast cancer (84.0%), followed by prostate cancer (16.0%). Exostosis was present in 9.3% of patients and the mean Decayed, Missing, Filled Teeth index was 4.64; 44.0% of the study group had a Community Periodontal Index value between 2 and 2.9 (mean, 0.60). A detailed intraoral assessment must be performed before initiating treatment with bisphosphonates to identify risk factors for osteonecrosis.
ISSN:2234-7550
2234-5930
DOI:10.5125/jkaoms.2016.42.6.365